SMS Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
SMS Pharmaceuticals has submitted a quarterly compliance certificate to the stock exchanges dated 10th July 2025, covering the period from 1st April 2025 to 30th June 2025. The certificate was issued by the company's Registrar and Share Transfer Agent, Aarthi Consultants Private Limited, confirming compliance with Regulation 74(5) of SEBI's Depositories Regulations. The RTA confirmed it processed dematerialization requests within 15 days, mutilated and cancelled the physical share certificates received, and updated the depository's name as the registered owner in its records. This is a routine procedural filing with no mention of any corporate action, financial result, or material event.
No impact on shareholders or stock price — this is a standard quarterly regulatory compliance filing confirming that share dematerialization requests were processed correctly during Q1 FY26. Investors can treat this as routine housekeeping.